Stockscreener 앱 받기
2.7851
4.30%
-0.1249
전일 마감가:
$2.91
열려 있는:
$2.92
하루 거래량:
119.20K
Relative Volume:
0.14
시가총액:
$385.12M
수익:
-
순이익/손실:
$-45.44M
주가수익비율:
-7.9574
EPS:
-0.35
순현금흐름:
$-42.28M
1주 성능:
-6.23%
1개월 성능:
+5.49%
6개월 성능:
-20.43%
1년 성능:
+209.44%
1일 변동 폭
$2.74
$2.92
1주일 범위
$2.74
$3.03
52주 변동 폭
$0.98
$4.08
Compass Therapeutics Inc Stock (CMPX) Company Profile
명칭
Compass Therapeutics Inc
전화
617-500-8099
주소
80 GUEST STREET, BOSTON
CMPX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
2.785 | 405.17M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.60 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.15 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.86 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
672.75 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
296.29 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 재개 | Raymond James | Outperform |
| 2025-04-02 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | 개시 | Guggenheim | Buy |
| 2025-02-19 | 개시 | Piper Sandler | Overweight |
| 2024-12-23 | 개시 | D. Boral Capital | Buy |
| 2024-11-15 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | 개시 | Jefferies | Buy |
| 2023-01-27 | 개시 | Stifel | Buy |
| 2022-05-23 | 재개 | H.C. Wainwright | Buy |
| 2022-03-15 | 개시 | Ladenburg Thalmann | Buy |
| 2022-01-19 | 개시 | B. Riley Securities | Buy |
| 2021-12-22 | 개시 | Raymond James | Outperform |
| 2021-12-20 | 개시 | SVB Leerink | Outperform |
| 2021-12-15 | 개시 | Wedbush | Outperform |
모두보기
Compass Therapeutics Inc 주식(CMPX)의 최신 뉴스
Will Compass Therapeutics Inc. continue its uptrendShort Squeeze Opportunities with Indicators - Newser
Has Compass Therapeutics Inc. formed a bullish divergenceChart-Based Entry Confirmation for Beginners - Newser
Earnings visualization tools for Compass Therapeutics Inc.Portfolio Positioning Strategy With Timing - Newser
Compass Therapeutics Inc. stock prediction for this weekShort Term Gain Strategy with AI Logic - Newser
What makes Compass Therapeutics Inc. stock price move sharplyFree Consistent Gain Investment Strategies - Newser
Is Compass Therapeutics Inc. forming a reversal patternIntraday Strategy with Real Time Monitoring - Newser
Using Ichimoku Cloud for Compass Therapeutics Inc. technicalsAI Trend Detection for Entry Timing - Newser
Detecting support and resistance levels for Compass Therapeutics Inc.Breakout Screener With Alert Based Timing - Newser
Heatmap analysis for Compass Therapeutics Inc. and competitorsFree Sector Based Breakout Stock Forecast - Newser
What does recent volatility data suggest for Compass Therapeutics Inc.Machine Learning Intraday Signal Forecast - Newser
Does Compass Therapeutics Inc. stock perform well during market downturnsDynamic growth stocks - Jammu Links News
How volatile is Compass Therapeutics Inc. stock compared to the marketInvest confidently with real-time updates - Jammu Links News
What are the latest earnings results for Compass Therapeutics Inc.Free Expert Stock Watchlist - Jammu Links News
What is the dividend policy of Compass Therapeutics Inc. stockUnlock powerful market trend analysis - Jammu Links News
What are analysts’ price targets for Compass Therapeutics Inc. in the next 12 monthsNavigate market shifts with confidence - Jammu Links News
What drives Compass Therapeutics Inc. stock priceAccelerated investment success - Jammu Links News
What institutional investors are buying Compass Therapeutics Inc. stockCapitalize on momentum-driven stocks - Jammu Links News
Is it the right time to buy Compass Therapeutics Inc. stockFree Stock Selection - Jammu Links News
Why is Compass Therapeutics Inc. stock attracting strong analyst attentionDynamic profit expansion - Jammu Links News
What are Compass Therapeutics Inc. company’s key revenue driversMarket-leading capital gains - Jammu Links News
When is the best time to exit Compass Therapeutics Inc.Short Term Opportunity Finder with Tools - Newser
Momentum divergence signals in Compass Therapeutics Inc. chartFree Fast Gaining Stock Screener Report - Newser
Price action breakdown for Compass Therapeutics Inc.Weekly Return Plan for Conservative Traders - Newser
Using data tools to time your Compass Therapeutics Inc. exitStrong Buy Signal Summary with Entry Zone - Newser
Can machine learning forecast Compass Therapeutics Inc. recoveryFree Low Volatility Stable Growth Picks - Newser
Is Compass Therapeutics Inc. stock a growth or value playLong-Term Safety Investment Analysis Report - Newser
Technical signs of recovery in Compass Therapeutics Inc.Bear Market Safe Zone Technical Analysis - Newser
What analysts say about Compass Therapeutics Inc. stock outlookFree AI-Powered Trade Planning with Indicators - Newser
Why Compass Therapeutics Inc. stock attracts strong analyst attentionSummary of Trade Cycles in 5-Year Range - Newser
Compass Therapeutics Inc. Rebound Backed by Sentiment ShiftAlpha Driven Watchlist With Alerts Published - metal.it
Can Compass Therapeutics Inc. Escape Recent Bear ChannelLow Risk High Return Opportunities Identified - metal.it
Published on: 2025-07-29 20:25:47 - metal.it
Is Compass Therapeutics Inc. a candidate for recovery playShort Term Opportunity Finder with Tools - Newser
Compass Therapeutics Inc. Rebounds From Oversold Zone — Now WhatEarly Breakout Entry Point Notifications Sent - metal.it
What is Compass Therapeutics Inc. company’s growth strategyFree Stock Trend Scanner For 2025 - jammulinksnews.com
Compass Therapeutics Inc (CMPX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Compass Therapeutics Inc 주식 (CMPX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
| ORBIMED ADVISORS LLC | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
0.43%
1.83%
자본화:
|
볼륨(24시간):